Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Di Liao

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Cellular and Molecular Life Sciences : CMLS|May 27, 2010
Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activationXiao-Feng Lu, En-Min Li, Ze-Peng Du, et al.
Oncology Reports|October 18, 2017
Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinomaPeng-Zhi Ni, Jian-Zhong He, Zhi-Yong Wu, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 26, 2010
The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological featuresWei-Sen Wang, Hai-Jun Zhong, Da-Wei Xiao, et al.
Human Pathology|January 17, 2016
Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinomaJian-Jun Xie, Jin-Cheng Guo, Zhi-Yong Wu, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2012
Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patientsNelson L S Tang, Chen Di Liao, Xingyan Wang, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2014
Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interactionChia-Hsien Lin, Jung-Kuei Chen, Tai-Ming Ko, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|October 3, 2014
Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinomaGuo-Qing Lv, Hai-Ying Zou, Lian-Di Liao, et al.
The International Journal of Biochemistry & Cell Biology|February 27, 2022
AKT serine/threonine kinase 2-mediated phosphorylation of fascin threonine 403 regulates esophageal cancer progressionZhi-Da Zhang, Bing Wen, Da-Jia Li, et al.
Human Pathology|June 13, 2017
A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinomaJian-Zhong He, Zhi-Yong Wu, Shao-Hong Wang, et al.
Cell Biochemistry and Function|November 29, 2018
The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrestYin-Wei Cheng, Lian-Di Liao, Qian Yang, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Cellular and Molecular Life Sciences : CMLS|May 27, 2010
Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activationXiao-Feng Lu, En-Min Li, Ze-Peng Du, et al.
Oncology Reports|October 18, 2017
Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinomaPeng-Zhi Ni, Jian-Zhong He, Zhi-Yong Wu, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 26, 2010
The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological featuresWei-Sen Wang, Hai-Jun Zhong, Da-Wei Xiao, et al.
Human Pathology|January 17, 2016
Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinomaJian-Jun Xie, Jin-Cheng Guo, Zhi-Yong Wu, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2012
Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patientsNelson L S Tang, Chen Di Liao, Xingyan Wang, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2014
Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interactionChia-Hsien Lin, Jung-Kuei Chen, Tai-Ming Ko, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|October 3, 2014
Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinomaGuo-Qing Lv, Hai-Ying Zou, Lian-Di Liao, et al.
The International Journal of Biochemistry & Cell Biology|February 27, 2022
AKT serine/threonine kinase 2-mediated phosphorylation of fascin threonine 403 regulates esophageal cancer progressionZhi-Da Zhang, Bing Wen, Da-Jia Li, et al.
Human Pathology|June 13, 2017
A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinomaJian-Zhong He, Zhi-Yong Wu, Shao-Hong Wang, et al.
Cell Biochemistry and Function|November 29, 2018
The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrestYin-Wei Cheng, Lian-Di Liao, Qian Yang, et al.
Pageof 18